Sp368

PANEL DISCUSSION WITH Q&A

Date
May 7, 2023
Explore related products in the following collection:

Society: AASLD

This program will focus on the concept of imposter syndrome and how women can address their perceptions of value and worth to optimize leadership opportunities and work satisfaction. We will start with a keynote speech from a female gastroenterologist with experience in this arena, followed by a panel Q&A including three female leaders from across our GI societies. Program Co-Chairs: Dr. Monika Sarkar (AASLD) and Dr. Rinarani Sanghavi (NASPGHAN).

Presenters

Speaker Image for Lauren Nephew
Indiana University School of Medicine
Speaker Image for Amandeep Shergill
University of California San Francisco
Speaker Image for Jenifer Lightdale
UMass Memorial Medical Center University Campus

Tracks

Related Products

Thumbnail for HIGH COMPLIANCE OF AASLD CIRRHOSIS QUALITY MEASURES IS ASSOCIATED WITH IMPROVED OUTCOMES IN CIRRHOSIS WITH ACUTE VARICEAL BLEEDING: SINGAPORE NATIONWIDE AUDIT
HIGH COMPLIANCE OF AASLD CIRRHOSIS QUALITY MEASURES IS ASSOCIATED WITH IMPROVED OUTCOMES IN CIRRHOSIS WITH ACUTE VARICEAL BLEEDING: SINGAPORE NATIONWIDE AUDIT
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
Thumbnail for POLYPHARMACY IS ASSOCIATED WITH OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
POLYPHARMACY IS ASSOCIATED WITH OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
BACKGROUND: Due to development of an immune dysregulated phenotype, advanced liver disease in all its forms predisposes to sepsis acquisition and related mortality…
Thumbnail for GLOBAL EPIDEMIOLOGY OF CIRRHOSIS: CHANGING ETIOLOGICAL BASIS AND DISEASE BURDEN BETWEEN FEMALES AND MALES
GLOBAL EPIDEMIOLOGY OF CIRRHOSIS: CHANGING ETIOLOGICAL BASIS AND DISEASE BURDEN BETWEEN FEMALES AND MALES
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…